1. active substance
2. Product form
6. dosage and Administration
7. Side effects
9. Terms and Conditions of storage
Detruzitol - a drug that can help reduce urinary tract smooth muscle tone.
drug is available in the form of hard gelatin capsules, sustained-release 2 mg (capsule size - №4, body and cap blue-green color with the number "2" on the body anddrawing a man on the lid) and 4 mg (capsule size - №3, body and cover of blue with the number "4" on the body and patterned as a man on the lid).Capsules
implemented in blisters to 7 pieces in cardboard packs (1, 4, 7, 12 and 40 in each of blisters).
Capsules 2 mg
Valium Valium, Surelease E-7-19010 Clear (oleic acid, medium-chain triglycerides, ethyl cellulose), sugar pellets (corn starch, sucrose,).
shell composition: gelatin, titanium dioxide, iron oxide yellow dye, indigo, white ink OpacodeWhiteS-1-7085 (simethicone, titanium dioxide, shellac, propylene glycol).
Capsules 4 mg
Excipients: SureleaseE-7-19010 Clear (medium chain triglycerides, ethyl cellulose, oleic acid), sugar granules (maize starch, sucrose), hypromellose.
shell composition: white ink OpacodeWhiteS-1-7085 (propylene glycol, titanium dioxide, simethicone, shellac), titanium dioxide, indigo carmine, gelatin.
Indications Indications for use Detruzitola is overactive bladder, characterized by mandatory, frequent urination, and frequent urination or urinary incontinence.
Contraindications The drug is contraindicated in the following situations apply:
Detruzitol With caution is prescribed for such pathological conditions as:
Also, the drug is prescribed with caution in pregnant or lactating women, persons taking antiarrhythmics class 1A (procainamide, quinidine) and Class 3 (sotalol, amiodarone).
Detruzitol applied orally.Capsules are taken without regard to meals.The recommended daily dose is 4 mg.Multiplicity of reception - 1 times per day.Dose can be reduced to 2 mg per day, based on individual tolerance tolterodine.
patients taking potent inhibitors of CYP3A4 (as a co-treatment), as well as persons suffering from disorders of the kidneys and liver, analyzed the drug is prescribed in a dose of 2 mg per day.
The capsules should be swallowed whole (crush and chew contraindicated).
Reception Detruzitola can trigger the development of such adverse reactions as:
Side effects identified in post-marketing research:
patients, combining tolterodine with cholinesterase inhibitors, may have worsening symptoms of dementia (hallucinations, disorientation, confusion).
Detruzitolom Overdose is characterized by the following symptoms: difficulty urinating or urinary retention, mydriasis, accommodation disorders, severe agitation, hallucinations, convulsions, tachycardia, respiratory failure.
overdose Treatment includes gastric lavage, activated charcoal and symptomatic therapy.In marked excitation or convulsions prescribed benzodiazepine anxiolytics structure;during hallucinations - physostigmine;respiratory failure - artificial respiration;with urinary retention - catheterization of the bladder;tachycardia - beta-blockers.Mydriasis When the patient is transferred into a dark room, or prescribe pilocarpine (eye drops).Also, with an overdose of taking the necessary measures in connection with prolongation of the QT interval.
Women of childbearing age at the time of treatment must use reliable methods of contraception.
Before therapy is necessary to exclude organic causes of mandatory and frequent urge to urinate.
During reception Detruzitola should refrain from potentially hazardous activities that require speed of psychomotor reactions, and high concentration, as well as driving a car, as tolterodine reduces the rate of reaction and cause accommodation disturbances.
Store in a dry, dark and protected from children, at room temperature, no more than +25 ° C.
Shelf life - 2 years.
After the expiration date, the drug taking is strictly prohibited.
Product description posted on this page is a supplement and a simplified version of the official version of the annotations to the drug.The information is provided for informational purposes only and is not a guide to self-medication.Before using the product you should consult with a specialist and to get acquainted with the instructions approved by the manufacturer.
Contents: 1. release form and pharmacological properties 2. Indications libeksin 3. Instruction libeksin: method of use and dosag...
Contents: 1. Product form Lespefrila 2. Indications drug Lespefril 3. Contraindications 4. Guide Lespefrila 5. Sideaction...
Contents: 1. Instruction Lespeflanu: indications for use 2. Instruction Lespeflanu: side effects and contraindications 3. Additio...